Hijack stars Idris Elba, Christine Adams, Max Beesley, Archie Panjabi, Christian Näthe, Clare-Hope Ashitey, Lisa Vicari, Toby Jones, Karima McAdams, and Christiane Paul. “executive produced by SAG ...

Zack Snyder recently posted a photo carousel on Instagram, which includes photos reportedly from Justice League 2 and 3’s storyboard — shown in the fifth and sixth slides. Also shown in the carousel ...

"It's going to really start to infringe on how we're telling these stories," said the star of the new Netflix crime flick "The Rip." Mekishana Pierre is a news writer at Entertainment Weekly. She has ...

While Percy Jackson Season 2 continues to release weekly episodes, the team is already in production for Season 3, which will adapt Rick Riordan’s third book, The Titan’s Curse. In an interview with ...

Power Book IV: Force stars Joseph Sikora, Isaac Keys, Shane Harper, Kris D. Lofton, Anthony Fleming III, Lucien Cambric, Tommy Flanagan, Carmela Zumbado, Manuel Eduardo Ramirez, Miriam A. Hyman, and ...

Watch With Us couldn’t be more excited for the return of the hit Netflix crime thriller, The Night Agent. The Night Agent follows FBI Agent Peter Sutherland (Gabriel Basso), who first began the show ...

The Tulsa King finale, “Jesus Lizard,” wraps up with Dwight Manfredi back on top, saving the day like it’s second nature. Honestly, as someone who’s been riding along with Dwight (Sylvester Stallone) ...

Today was a day that many movie lovers never thought would happen: we got an official announcement that Gremlins 3 was in production, with original Gremlins and Gremlins 2 writer Chris Columbus ...

The third installment will hit theaters on Nov. 19, 2027. It’s official — the Gremlins are returning to the big screen. Warner Bros. has officially greenlit Gremlins 3, marking the first new ...

DEARBORN, Mich. (WXYZ) — A third Dearborn man has been arrested and charged in connection with an alleged terror plot targeting Ferndale on Halloween. The FBI also ...

BridgeBio Pharma is having a banner week, with the Bay Area company’s encaleret acing a phase 3 trial just days after another late-stage rare disease win as its eyes an FDA review in 2026. In the ...